Document is current
Any future updates will be listed below
-
Authors
Liu, Chuang https://orcid.org/0000-0002-2445-0845
Huang, Xiangang https://orcid.org/0000-0001-8948-7879
Chen, Kok-Siong
Xiong, Sihan
Yaremenko, Alexey V. https://orcid.org/0000-0003-0708-5214
Zhen, Xueyan https://orcid.org/0009-0006-0611-529X
You, Xinru
Rossignoli, Filippo https://orcid.org/0000-0001-7838-1542
Tang, Yi https://orcid.org/0009-0009-1019-1174
Koo, Seyoung
Chen, Wei https://orcid.org/0000-0002-2909-3023
Kong, Na
Xie, Tian
Shah, Khalid
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 19 June 2025
First Online: 11 August 2025
Competing interests
: C.L., N.K. and W.T. are inventors on a US patent application (BWH Invention no. 2025-409) filed by the Brigham and Women’s Hospital related to the technology disclosed here. W.T. has received consultancy fees, lecture fees, been on the scientific advisory board or conducted sponsored research at Harvard Medical School/Brigham and Women’s Hospital for the following entities: Novo Nordisk A/S, Henlius USA Inc. K.S. owns equity in and is a member of the Board of Directors of AMASA Therapeutics, a startup company developing stem-cell-based therapies for cancer. K.S.’s interests were reviewed and are managed by Brigham and Women’s Hospital and Mass General Brigham in accordance with their conflict-of-interest policies. The other authors declare no competing interests.
